Use of VEGF-C or VEGF-D Gene or Protein to Prevent Restenosis

Details for Australian Patent Application No. 2004201020 (hide)

Owner Ludwig Institute For Cancer Research Licentia Ltd. Seppo Yla-Herttuala

Inventors Yla-Herttuala, Seppo; Jeltsch, Markku M.; Hiltunen, Mikko O.; Achen, Marc G; Alitalo, Kari

Agent Spruson & Ferguson

Pub. Number AU-A-2004201020

Parent 768330

Filing date 11 March 2004

Wipo publication date 8 April 2004

International Classifications

A61K 038/00 Medicinal preparations containing peptides

Event Publications

25 March 2004 Complete Application Filed

8 April 2004 Application Open to Public Inspection

  Published as AU-A-2004201020

14 October 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004201021-Adjuvants for Use in Vaccines

2004201019-Prosthesis with sustained release analgesic